Cargando…
Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
Circular RNAs (circRNAs) are single-stranded RNA molecules often circularized by backsplicing. Growing evidence implicates circRNAs in the underlying mechanisms of various diseases, such as Alzheimer’s and Parkinson’s disease (PD)—the first and second most prevalent neurodegenerative disorders. In t...
Autores principales: | Titze-de-Almeida, Simoneide Souza, Titze-de-Almeida, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459713/ https://www.ncbi.nlm.nih.gov/pubmed/37631249 http://dx.doi.org/10.3390/pharmaceutics15082035 |
Ejemplares similares
-
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
por: Titze-de-Almeida, Simoneide S., et al.
Publicado: (2020) -
Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag(®)
por: Titze de Almeida, Simoneide Souza, et al.
Publicado: (2018) -
The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells
por: Horst, Camila Hillesheim, et al.
Publicado: (2017) -
Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide
por: Sales, Thais Torquato, et al.
Publicado: (2016) -
circRNA disease: a manually curated database of experimentally supported circRNA-disease associations
por: Zhao, Zheng, et al.
Publicado: (2018)